Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research
Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study was intended to assess the efficacy and safety of different Disease-Modifying
Antirheumatic Drugs cycle combination regimen using the American College of Rheumatology
(ACR) criteria of 20% improvement in symptoms (ACR20) in managing active adult rheumatoid
arthritis.